Ribociclib and Letrozole Treatment in Ovarian Cancer
Ribociclib and Letrozole Treatment in Ovarian Cancer
Active, not recruiting · NCT03673124 · Registry updated 2025-12-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ribociclib and Letrozole Treatment in Ovarian Cancer | Cystadenocarcinoma, Serous, Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cystadenocarcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2025-12-23 | NCT03673124 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gynecologic Oncology Group | 9 |
| Novartis | 114 |
27 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.